Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has been assigned a consensus rating of "Hold" from the seven analysts that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $5.9375.
Several research analysts have commented on the stock. Wall Street Zen cut shares of Aspen Aerogels from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. B. Riley Financial reiterated a "buy" rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Barclays increased their target price on Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a report on Tuesday, August 11th. Weiss Ratings restated a "sell (d-)" rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. Finally, Roth Capital reaffirmed a "buy" rating and set a $7.75 price objective on shares of Aspen Aerogels in a research report on Friday, August 7th.
Get Our Latest Stock Analysis on ASPN
Hedge Funds Weigh In On Aspen Aerogels
A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASPN. Raymond James Financial Inc. increased its stake in Aspen Aerogels by 6.8% in the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company's stock valued at $157,000 after purchasing an additional 1,687 shares during the last quarter. Concurrent Investment Advisors LLC lifted its position in shares of Aspen Aerogels by 6.7% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 32,050 shares of the construction company's stock worth $203,000 after buying an additional 2,000 shares during the last quarter. California State Teachers Retirement System boosted its holdings in shares of Aspen Aerogels by 64.2% in the 2nd quarter. California State Teachers Retirement System now owns 5,890 shares of the construction company's stock valued at $37,000 after buying an additional 2,302 shares in the last quarter. Legal & General Group Plc boosted its holdings in shares of Aspen Aerogels by 3.6% in the 2nd quarter. Legal & General Group Plc now owns 67,130 shares of the construction company's stock valued at $397,000 after buying an additional 2,324 shares in the last quarter. Finally, Osaic Holdings Inc. grew its position in shares of Aspen Aerogels by 29.1% in the 2nd quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company's stock valued at $63,000 after buying an additional 2,390 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.
Aspen Aerogels Trading Up 3.0%
NYSE ASPN opened at $4.90 on Friday. The firm has a 50 day simple moving average of $5.20 and a 200-day simple moving average of $4.74. The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.24 and a current ratio of 2.52. Aspen Aerogels has a one year low of $2.30 and a one year high of $9.35. The firm has a market cap of $406.90 million, a price-to-earnings ratio of -3.20 and a beta of 2.97.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. The firm had revenue of $49.85 million during the quarter, compared to analysts' expectations of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. Equities research analysts anticipate that Aspen Aerogels will post -0.69 EPS for the current fiscal year.
Aspen Aerogels Company Profile
(
Get Free Report)
Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.
The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.